Health Care [ 8/12 ] | Biotechnology [ 51/73 ]
NASDAQ | Common Stock
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.
It has license and supply agreement with Sopharma AD and University of Bristol.
Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 25 | -0.37 Decreased by -48.00% | -0.37 |
| May 7, 25 | -0.37 Decreased by -42.31% | -0.37 Decreased by -1.18% |
| Mar 26, 25 | -0.36 Decreased by -38.46% | -0.36 |
| Nov 7, 24 | -0.36 Decreased by -5.88% | -0.26 Decreased by -38.46% |
| Aug 13, 24 | -0.25 Increased by +41.86% | -0.23 Decreased by -8.70% |
| May 9, 24 | -0.26 Increased by +48.00% | -0.24 Decreased by -8.33% |
| Mar 13, 24 | -0.26 Increased by +68.67% | -0.31 Increased by +16.13% |
| Nov 9, 23 | -0.34 Increased by +74.81% | -0.38 Increased by +10.53% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -12.72 M Decreased by -50.31% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -12.83 M Decreased by -97.52% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 228.00 K Increased by +N/A% | -12.36 M Decreased by -125.71% | Decreased by -5.42 K% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -12.51 M Decreased by -76.03% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -8.46 M Decreased by -2.69% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -6.49 M Increased by +27.78% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -5.48 M Increased by +50.17% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -7.11 M Increased by +47.57% | Decreased by N/A% Decreased by N/A% |